Adenosine receptor antagonists improve short-term object-recognition ability of spontaneously hypertensive rats: A rodent model of attention-deficit hyperactivity disorder

Behavioural Pharmacology

Volumn 20, Issue 2, 2009, Pages 134-145

  Pires, Vanessa A ^a   Pamplona, Fabrício A ^a   Pandolfo, Pablo ^a   Fernandes, Daniel ^a   Prediger, Rui D S ^a   Takahashi, Reinaldo N ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

8 cyclopenthyl 1,3 dipropylxanthine; Adenosine receptors; Attention deficit hyperactivity disorder; Caffeine; Methylphenidate; Object recognition task; Spontaneously hypertensive rats; ZM241385

Indexed keywords

4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; CAFFEINE; METHYLPHENIDATE; 1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE; ADENOSINE A2 RECEPTOR; TRIAZINE DERIVATIVE; TRIAZOLE DERIVATIVE; XANTHINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION DEFICIT DISORDER; BLOOD PRESSURE; COGNITIVE DEFECT; CONTROLLED STUDY; DISCRIMINATION LEARNING; DRUG EFFECT; FEMALE; GENETIC MODEL; MALE; MOUSE STRAIN; NONHUMAN; OUTBRED STRAIN; RAT; RAT STRAIN; RECOGNITION; SHORT TERM MEMORY; SPONTANEOUSLY HYPERTENSIVE RAT; TASK PERFORMANCE; TREATMENT PLANNING; WISTAR RAT; ANIMAL; COMPARATIVE STUDY; DISEASE MODEL; DRUG ANTAGONISM; PHYSIOLOGY;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BLOOD PRESSURE; CAFFEINE; DISEASE MODELS, ANIMAL; FEMALE; MALE; MEMORY, SHORT-TERM; METHYLPHENIDATE; RATS; RATS, INBRED SHR; RATS, WISTAR; RECEPTOR, ADENOSINE A1; RECEPTORS, ADENOSINE A2; RECOGNITION (PSYCHOLOGY); TRIAZINES; TRIAZOLES; XANTHINES;

EID: 66549095607     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e32832a80bf     Document Type: Article

References (87)

1. Adriani W, Laviola G (2004). Windows of vulnerability to phychopathology and therapeutic strategy In the adolescent rodent model. Behav Pharmacol15:341-352.
2. Alsop B (2007). Problems with spontaneously hypertensive rats (SHR) as a model of attention-deficit/hyperactivity disorder (AD/HD). J Neurosci Methods162:42-48.
3. Amini B, Yang PB, Swann AC, Dafny N (2004). Differential locomotor responses in male rats from three strains to acute methylphenidate. Int J Neurosci114:1063-1084.
4. Angelucci ME, Vital MA, Cesário C, Zadusky CR, Rosalen PL, Da Cunha C (1999). The effect of caffeine in animal models of learning and memory. Eur J Pharmacol373:135-140.
5. Angelucci ME, Cesario C, Hiroi RH, Rosalen PL, Da Cunha C (2002). Effects of caffeine on learning and memory in rats tested in the Morris water maze. Braz J Med Biol Res35:1201 -1208.
6. Berger FD, Sagvolden T (1998). Sex differences in operant discrimination behaviour in an animal model of attention-deficit hyperactivity disorder. Behav Brain Res94:73-82.
7. Biederman J, Faraone SV, Spencer T, Wilens T, Mick E, Lapey KA (1994). Gender differences in sample of adults with attention deficit hyperactivity disorder. Psychiatry Res53:13-29.
8. Birkenhager WH, Forette F, Seux ML, Wang JG, Staessen JA (2001). Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertension. Arch Intern Med61:152-156.
9. Bucci DJ, Hopkins ME, Keene CS, Sharma M, Orr LE (2008a). Sex differences in learning and Inhibition In spontaneously hypertensive rats. Behav Brain Res187:27-32.
10. Bucci DJ, Hopkins ME, Nunez AA, Breedlove SM, Sisk CL, Nigg JT (2008b). Effects of sex hormones on associative learning in spontaneously hypertensive rats. Physiol Behav93:651 -657.
11. Castellanos FX, Tannock R (2002). Neuroscience of attention deficit/hyperactivity disorder: the search for endophenotypes. Net Rev Neurosci3:617-628.
12. Cunha RA (2001). Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem Int38:107-125.
13. Davids E, Zhang K, Tarazi FI, Baldessarlni RJ (2003). Animal models of attention-deficit hyperactivity disorder. Brain Res Brain Res Rev42:1-21.
14. Davies LP, Hambley JW, Johnston GAR (1987). Reduced adenosine deaminase activity in the CNS of spontaneously hypertensive rats. Neurochem Int10:533-536.
15. De Bruin NMWJ, Kiliaan AJ, De Wilde MC, Broersen LM (2003). Combined uridine and choline administration improves cognitive deficits in spontaneously hypertensive rats. Neurobiol Learn Mem80:63-79.
16. De Mendonça A, Ribeiro JA (1994). Endogenous adenosine modulates long-term potentiation in the hippocampus. Neuroscience62:385-390.
17. De Mendonça A, Almeida T, Bashir ZI, Ribeiro JA (1997). Endogenous adenosine attenuates long-term depression and depotentiation In the CA1 region of the rat hippocampus. Neuropharmacology36:161-167.
18. Diana G (2002). Does hypertension alone lead to cognitive decline in spontaneously hypertensive rats? Behav Brain Res 134:113-121.
19. Elias MF, Robbins MA, Schultz NR Jr, Sreeten DH, Elias PK (1987). Clinical significance of cognitive performance by hypertensive patients. Hypertension9:192-197.
20. Ennaceur A, Delacour J (1988). A new one-trial test for neurobiological studies of memory in rats. 1 : behavioral data. Behav Brain Res31:47-59.
21. Ernst M, Zametkin AJ, Matochik JA, Jons PH, Cohen RM (1998). DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18] fluorodopa positron emission tomographic study. J Neurosci 18:5901-6907.
22. Faraone SV, Sergeant J, Gillberg C, Biederman J (2003). The worldwide prevalence of ADHD: is It an American condition? World Psychiatry 2:104-113.
23. Farmer ME, White LR, Abbot RD, Kittner SJ, Kaplan E, Wolz MM, et al. (1987). Blood pressure and cognitive performance. The Framinghan Study. Am J Epidemiol126:1103-1114.
24. Ferguson AS, Cada AM (2004). Spatial learning/memory and social and nonsocial behaviors in the spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rat strains. Pharmacol Biochem Behav77: 583-594.
25. Fox GB, Pan JB, Esbenshade TA, Bennani YL, Black LA, Faghih R, et al. (2002). Effects of histamine H(3) receptor ligands GT-2331 and ciproxifan in a repeated acquisition avoidance response in the spontaneously hypertensive rat pup. Behav Brain Res131:151-161.
26. Fredholm BB, Bättig K, Holmén J, Nehlig A, Zvartau EE (1999). Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev51:83-133.
27. Fredholm BB, Ijzerman AP, Jacobson KA, Klotz KN, Linden J (2001). International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev53:527-552.
28. Gattu M, Pauly JR, Boss KL, Summers JB, Buccafusco JJ (1997a). Cognitive impairment in spontaneously hypertensive rats: role of central nicotinic receptors. Brain Res771:89-103.
29. Gattu M, Terry AV Jr, Pauly JR, Buccafusco JJ (1997b). Cognitive impairment in spontaneously hypertensive rats: role of central nicotinic receptors. Part II. Brain Res771:104-114.
30. Gaub M, Carlson CL (1997). Gender differences in ADHD: a meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry36:1036- 1045.
31. Gershon J (2002). A meta-analytic review of gender differences in ADHD. J Atten Disord5:143-164.
32. Gimenez-Llort L, Schiffmann SN, Shmidt T, Canela L, Camon L, Wassholm M, et al. (2007). Working memory deficits in trangenic rats overexpressing human adenosine human adenosine A2A receptors in the brain. Neurobiol Learn Mem87:42-56.
33. Hameleers PA. Van Boxtel MP, Hogervorst E, Riedel WJ, Houx PJ, Buntinx F, Jolies J (2000). Habitual caffeine consumption and its relation to memory, attention, planning capacity and psychomotor performance across multiple age groups. Hum Psychopharmacol15:573-581.
34. Hanson L (1999). Antihypertensive treatment and the prevention of dementia: further insights from the Syst-Eur trial. J Hypertens17: 307-308.
35. Haskell CF, Kennedy DO, Wesness KA, Scholey AB (2005). Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine. Psychopharmacology179:813-825.
36. Hecht K, Poppei M, Hecht T, Postnow JW, Moritz V, Baumann R (1978). Learning and memory processes during postnatal ontogenesis in rats with spontaneous hypertension, Acta Biol Med Ger 37:1471-1478.
37. Hernandez CM, Høifødt H, Terry AV Jr (2003). Spontaneously hypertensive rats: further evaluation of age-related memory performance and cholinergic marker expression. J Psychiatry Neurosci28:197-209.
38. Higgins GA, Grzelak ME, Pond AJ, Cohen-Williams ME, Hodgson RA, Varty GB (2007). The effect of caffeine to increase reaction time in the rat during a test of attention is mediated through antagonism of adenosine A(2A) receptors. Behav Brain Res185:32-42.
39. Himelstein J, Newcorn JH, Halperin JM (2000). The neurobiology of attention-deficit hyperactivity disorder. Front Biosci5:D461-D478.
40. Homayoun H, Khavandgar S, Zarrindast MR (2001). Effects of adenosine receptor agonists and antagonists on pentylenetetrazole-induced amnesia. Eur J Pharmacol430:289-294.
41. Illes P, Rickmann H, Brod I, Bucher B, Stoclet JC (1989). Subsensitlvity of presynaptic adenosine A1-receptors in caudal arteries of spontaneously hypertensive rats. Eur J Pharmacol174:237-251.
42. Izquierdo JA, Costas SM, Justei EA, Rabiller G (1979). Effects of caffeine on the memory of the mouse. Psychopharmacology61:29-30.
43. Jacobson KA, Gao ZG (2006). Adenosine receptors as therapeutic targets. Nat Rev Drug Discov5:247-264.
44. Jentsch JD (2005). Impaired vlsuospatial attention in the spontaneously hypertensive rat. Behav Brain Res157:323-330.
45. Kamikawa Y, Cline WH Jr, Su C (1980). Diminished purinergic modulation of the vascular adrenergic neurotransmission in spontaneously hypertensive rats. Eur J Pharmacol66:347-353.
46. Karcz-Kubicha M, Antonlou K, Terasmaa A, Quarta D, Solinas M, Justinova Z, et al. (2003). Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration. Neuropsychopharmacology28:1281-1291.
47. Knardahl S, Karlsen K (1984). Passive-avoidance behavior of spontaneously hypertensive rats. Beriav Neural Biol42:9-22.
48. Krause KH, Dresel SH, Krause J, la Fougere C, Ackenheil M (2003). The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder. Neurosci Biobehav Rev27:605-613.
49. Kuzmin A, Johansson B, Gimenez L, Ogren SO, Fredholm BB (2006). Combination of adenosine A1 and A2A receptor blocking agents induces caffeine-like locomotor stimulation iIn mice. Eur Neuropsycopharmacol16:129-136.
50. Linden J (2001). Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol41:775-787.
51. Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M (1993). Adult outcome of hyperactive boys. Educational achievement, occupational, and psychiatric status. Arch Gen Psychiatry50:565-576.
52. Matlas A, Zimmer FJ, Lorenzen A, Keil R, Schwabe U (1993). Affinity of central adenosine A1 receptors is decreased in spontaneously hypertensive rats. Eur J Pharmacol244:223-230.
53. Meneses A, Hong E (1998). Spontaneously hypertensive rats: a potential model to identify drugs for treatment of learning disorders. Hypertension31: 968-972.
54. Mori S, Kato M, Fujishima M (1996). Impaired maze learning and cerebral glucose utilization in aged hypertensve rats. Hypertension25:545- 553.
55. Muresanu DF, Sharma HS (2007). Chronic hypertension aggravates heat stress induced cognitive dysfunction and brain pathology: an experimental study in the rat, using growth hormone therapy for possible neuroprotection. Ann N Y Acad Sci1122:1-22.
56. Nakamura-Palacios EM, Caldas CK, Fiorini A, Chagas KD, Chagas KN, Vasquez EC (1996). Deficits of spatial learning and working memory in spontaneously hypertensive rats. Senav Brain Res74:217-227.
57. Nleoullon A (2002). Dopamine and the regulation of cognition and attention. Prog Neurobiol67:53-83.
58. Nigg JT, Blaskey LG, Huang-Pollock CL, Rappley MD (2002). Neuropsychological executive functions and DSM-IV ADHD subtypes. J Am Acad Child Adolesc Psychiatry41:59-66.
59. Norman G, Eacott MJ (2004). impaired object recognition with increasing levels of feature ambiguity In rats with perirhinal cortex lesions. Behav Brain Res148:79-91.
60. Normile HJ, Barraco RA (1991). N6-cyclopentyladenoslne Impairs passive avoidance retention by selective action at A1 receptors. Brain Res Bull27:101-104.
61. Ohno M, Watanabe S (1996). Working memory failure by stimulation of hlppocampal adenosine A1 receptors In rats. Neuroreport25:3013- 3016.
62. Pandolfo P, Pamplona FA, Prediger RD, Takahashi RN (2007). increased sensitivity of adolescent spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder, to the locomotor stimulation induced by the cannablnold receptor agonist WIN 55,212-2. Eur J Pharmacol563:141-148.
63. Papa M, Diewald L, Carey MP, Esposlto FJ, Girondl Carnevale UA, Sadile AG (2002). A rostro-caudal dissociation in the dorsal and ventral striatum of the juvenile SHR suggests an anterior hypo- and posterior hyperfunctioning mesocorticollmbic system. Behav Brain Res130:171-179.
64. Prediger RD, Fernandes D, Takahashi RN (2005a). Blockade of adenosine A2A receptors reverses short-term social memory impairments in spontaneously hypertensive rats. Behav Brain Res159:197-205.
65. Prediger RD, Pamplona FA, Fernandes D, Takahashi RN (2005b). Caffeine improves spatial learning deficits in an animal model of attention deficit hyperactivity disorder (ADHD) -the spontaneously hypertensive rat (SHR). Int J Neuropsychopharmacol8:583-594.
66. Ramos A, Berton O, Mormède P, Chaouloff F (1996). A multiple-test study of anxiety-related behaviours in six inbred rat strains. Behavioral Brain Research85:57-69.
67. Ribeiro JA, Sebastião AM, de Mendonça A (2003). Adenosine receptors in the nervous system: pathophysiological Implications. Prog Neurobiol68:377-392.
68. Robertson BA, Clements KM, Wainwright PE (2008). The working memory capabilities of the spontaneously hypertensive rat. Physiol Behav94:481-486.
69. Russell VA (2002). Hypodopamlnergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder - the spontaneously hypertensive rat. Behav Brain Res130:191-196.
70. Russell VA, de Villiers A, Sagvolden T, Lamm M, Taljaard J (1998). Differences between eletrically-ritalin-and D-amphetamlne-stimulanted released of [3H]dopamine from brain slices suggest Impaired vesicular storage of dopamine in an animal model of Attention-Deficit Hyperactivity Disorder. Behav Brain Res94:163-171.
71. Sagvolden T (2000). Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci Biobehav Rev24:31-39.
72. Sagvolden T, Sergeant JA (1998). Attention deficit/hyperactivity disorder - from brain dysfunction to behaviour. Behav Brain Res94:1-10.
73. Sagvolden T, Xu T (2008). L-Amphetamine improves poor sustained attention while D-amphetamine reduces overactivity and impulsiveness as well as improves sustained attention in an animal model of Attention-Deficit/ Hyperactivity Disorder (ADHD). Behav Brain Funct4:3.
74. Smit HJ, Rogers PJ (2000). Effects of low doses of caffeine on cognitive performance, mood and thirst in low and higher caffeine consumers. Psychopharmacology152:167-173.
75. Sutterer JR, Perry J, De Vito W (1980). Two-way shuttle box and lever-press avoidance In the spontaneously hypertensive and normotensive rat. J Comp Physiol Psychol94:155-163.
76. Swanson JM, Flodman P, Kennedy J, Spence MA, Moyzls R, Schuck S, et al. (2000). Dopamine genes and ADHD. Neurosci Biobehav Rev24:21-25.
77. Takahashi RN, Pamplona FA, Prediger RD (2008). Adenosine receptor antagonist for cognitive dysfunction: a review of animal studies. Front Biosci13:2614-2632.
78. Taylor E (1998). Clinical foundations of hyperactivity research. Behav Brain Res94:11-24.
79. Terry AV Jr, Hernandez CM, Buccafusco JJ, Gattu M (2000). Deficits In spatial learning and nicotinic-acetylcholine receptors in older, spontaneously hypertensive rats. Neuroscience101:357-368.
80. Ueno KI, Togashi H, Mori K, Matsumoto M, Ohashi S, Hoshino A, et al. (2002). Behavioural and pharmacological relevance of stroke-prone spontaneously hypertensive rats as an animal model of a developmental disorder. Behav Pharmacol13:1-13.
81. Van Boxtel MP, Schmitt JA, Bosma H, Jolles J (2003). The effects of habitual caffeine use on cognitive change: a longitudinal perspective. Pharmacol Biochem Behav75:921-927.
82. Van den Bergh FS, Bloemants E, Chan JS, Groenink L, Olivier B, Oosting RS (2006). Spontaneously hypertensive rats do not predict symptoms of attentiondeficit hypertensive disorder. Pharmacol Biochem Behav83:380-390.
83. Wolralch ML, Hannah JN, Pinnock TY, Baumgaertel A, Braown J (1996). Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. J Am Acad Child Adolesc Psychiatry35:319- 324.
84. Wyss JM, Fisk G, van Groen T (1992). Impaired learning and memory in mature spontaneously hypertensive rats. Brain Res592:135-140.
85. Wyss JM, Chambless BD, Kadish I, van Groen T (2000). Age-related decline in water maze learning and memory in rats: strain differences. Neurobiol Aging21:671-681.
86. Yang PB, Swann AC, Dafny N (2006). Acute and chronic methylphenidate doseresponse assessment on three adolescent male rat strains. Brain Res Bull71:301-310.
87. Zarrindast MR, Shafaghl B (1994). Effects of adenosine receptor agonists and antagonists on acquisition of passive avoidance learning. Eur J Pharmacol256:233-239.